stockrowBioAge Labs, Inc. (BIOA) vs Lifecore Biomedical, Inc. (LFCR)
- BioAge Labs, Inc. BIOA 5.34 −3.61%
- Lifecore Biomedical, Inc. LFCR 6.38 −0.31%
BioAge Labs, Inc. and Lifecore Biomedical, Inc. are both Drug Manufacturers Specialty & Generic companies. BioAge Labs, Inc. and Lifecore Biomedical, Inc. are of similar size ($254.3M and $242.6M). Lifecore Biomedical, Inc. has the higher net margin (−65.9% vs −1,253.6%) and the higher return on invested capital (0.00% vs −21.8%). Across the 14 metrics below, Lifecore Biomedical, Inc. leads on 9 and BioAge Labs, Inc. on 5.
Valuation
Profitability
| Metric | BIOA | LFCR | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 100.00% | 27.38% | 53.51% |
| Operating margin | (1,401.81%) | (5.33%) | 0.00% |
| Net margin | (1,253.60%) | (65.91%) | (2.45%) |
| Free cash flow margin | (2,997.41%) | 9.86% | 0.00% |
| Return on equity | (34.56%) | 178.69% | (0.80%) |
| Return on assets | (32.05%) | (32.36%) | (1.67%) |
| Return on invested capital | (21.75%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack